| Zeit | Aktuelle Nachrichten
Sprache: | | Leser | Medien |
|---|
| 19.06. | Uptrend Call Working As Idenix Pharmaceuticals Stock Rises 18.8% | | - | SmarTrend |
| 10.06. | IDENIX PHARMACEUTICALS INC - 8-K, Current Report | | 5 | SEC Filings |
| 07.06. | Shares of Idenix Pharmaceuticals Receive a Boost, Up 6.8% | | 5 | SmarTrend |
| 05.06. | Why Idenix Is Poised to Pull Back | | 8 | Motley Fool |
| 31.05. | Idenix Pharma Initiates Phase II Study | | 5 | Zacks |
| 31.05. | Idenix Pharmaceuticals' CEO Presents at Deutsche Bank Securities 38th Annual Health Care Conference (Transcript) | | 3 | Seeking Alpha |
| 30.05. | Idenix Pharma Begins Phase II All-Oral Combo Trial of Samatasvir, Simeprevir for HCV Infection | | 1 | Benzinga.com |
| 30.05. | Idenix Pharma (IDIX) Initiates Phase II HELIX-1 | | - | StreetInsider.com |
| 29.05. | Possible Bearish Inside Day Candle Pattern Detected for Idenix Pharmaceuticals | | - | SmarTrend |
| 28.05. | Hot Stock: Idenix Pharmaceuticals, Shares Gain 5.1% | | 4 | SmarTrend |
| 21.05. | Idenix Pharmaceuticals' CEO Presents at UBS Global Healthcare Services Conference (Transcript) | | 1 | Seeking Alpha |
| 16.05. | Idenix Pharmaceuticals' CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript) | | 13 | Seeking Alpha |
| 08.04. | Idenix Announces Data Presentation at the 48th Annual Meeting of the European Association for the Study of the Liver (EASL) | | 6 | Benzinga.com |
| 01.04. | Shares of Idenix Pharmaceuticals Has Fallen Below Previous 52-Week Low | | 4 | SmarTrend |
| 28.03. | Setback for Idenix Pharma | | 16 | Zacks |
| 28.03. | Idenix to proceed with hepatitis C candidate despite patent flap | | 5 | bizjournals |
| 25.03. | Why Idenix Pharmaceuticals Shares Flopped | | 16 | Motley Fool |
| 25.03. | Idenix Pharmaceuticals' CEO Presents Idenix Provides Update on Patent Interference (Transcript) | | 2 | Seeking Alpha |
| 25.03. | Idenix Loses First Phase Of Patent Dispute With Gilead Sciences | | 14 | The Street |
| 22.03. | Idenix Pharma (IDIX) Receives Adverse Decision in HCV Patent Filing; Will Appeal | | 4 | StreetInsider.com |